Wasatch Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wasatch Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-157,681	Closed	-$2.03M	–	391
2014 Q4	$2.03M	Sell	157,681 -81,348	-34%	-$1.02M	0.02%	313
2014 Q3	$2.94M	Sell	239,029 -171,672	-42%	-$1.99M	0.03%	291
2014 Q2	$6.5M	Buy	410,701 +4,144	+1%	+$59.1K	0.06%	236
2014 Q1	$6.15M	Sell	406,557 -444,008	-52%	-$5.01M	0.06%	236
2013 Q4	$6.48M	Sell	850,565 -189,126	-18%	-$1.02M	0.06%	225
2013 Q3	$3.51M	Buy	1,039,691 +298,080	+40%	+$786K	0.04%	268
2013 Q2	$1.82M	Buy	+741,611	New	+$1.78M	0.02%	314

Other funds holding HZNP

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return